Digital Repository

Neurological disorders associated with COVID-19 in Sri Lanka

Show simple item record

dc.contributor.author Chang, T.
dc.contributor.author Wijeyekoon, R.
dc.contributor.author Keshavaraj, A.
dc.contributor.author Ranawaka, U.
dc.contributor.author Senanayake, S.
dc.contributor.author Ratnayake, P.
dc.contributor.author Senanayake, B.
dc.contributor.author Caldera, M.C.
dc.contributor.author Pathirana, G.
dc.contributor.author Sirisena, D.
dc.contributor.author Wanigasinghe, J.
dc.contributor.author Gunatilake, S.
dc.contributor.author ASN COVID-19 Study Group
dc.date.accessioned 2023-10-06T09:02:01Z
dc.date.available 2023-10-06T09:02:01Z
dc.date.issued 2023
dc.identifier.citation BMC Neurology.2023;23(1):351 en_US
dc.identifier.issn 1471-2377
dc.identifier.uri http://repository.kln.ac.lk/handle/123456789/26726
dc.description Indexed In MEDLINE en_US
dc.description.abstract BACKGROUND: Neurological manifestations of SARS-CoV-2 infection have been reported from many countries around the world, including the South Asian region. This surveillance study aimed to describe the spectrum of neurological disorders associated with COVID-19 in Sri Lanka. METHODS: COVID-19 patients manifesting neurological disorders one week prior and up to six weeks after infection were recruited from all the neurology centres of the government hospitals in Sri Lanka from May 2021 – May 2022. Data was collected using a structured data form that was electronically transmitted to a central repository. All patients were evaluated and managed by a neurologist. Data were analysed using simple descriptive analysis to characterise demographic and disease related variables, and simple comparisons and logistic regression were performed to analyse outcomes and their associations. RESULTS: One hundred and eighty-four patients with neurological manifestations associated with COVID-19 were recruited from all nine provinces in Sri Lanka. Ischaemic stroke (31%) was the commonest neurological manifestation followed by encephalopathy (13.6%), Guillain–Barre syndrome (GBS) (9.2%) and encephalitis (7.6%). Ischaemic stroke, encephalitis and encephalopathy presented within 6 days of onset of COVID-19 symptoms, whereas GBS and myelitis presented up to 10 days post onset while epilepsy and Bell palsy presented up to 20 – 40 days post onset. Haemorrhagic stroke presented either just prior to or at onset, or 10 – 25 days post onset of COVID-19 symptomatic infection. An increased frequency of children presenting with encephalitis and encephalopathy was observed during the Omicron variant predominant period. A poor outcome (no recovery or death) was associated with supplemental oxygen requirement during admission (Odds Ratio: 12.94; p=0.046). CONCLUSIONS: The spectrum and frequencies of COVID-19 associated neurological disorders in Sri Lanka were similar to that reported from other countries, with strokes and encephalopathy being the commonest. Requiring supplemental oxygen during hospitalisation was associated with a poor outcome. en_US
dc.language.iso en en_US
dc.publisher BioMed Central, en_US
dc.subject COVID-19 en_US
dc.subject SARS-CoV-2 en_US
dc.subject Neurology en_US
dc.subject Sri Lanka en_US
dc.title Neurological disorders associated with COVID-19 in Sri Lanka en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Digital Repository


Browse

My Account